Viewing nowLipido Down Capsule 60mg (Orlistat)
Orlistat 60mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 200806047 · Approved 2008.06.02
Treatment of obesity (weight loss and maintenance); prevention of weight regain
This medication assists in weight loss or maintenance combined with a low-calorie diet in patients with obesity who have a body mass index (BMI) of 30 kg/m² or higher, or who are over 27 kg/m² with risk factors such as hypertension, diabetes, or dyslipidemia. It is also used to reduce the risk of weight regain, thus effective for treating obesity and managing weight.
The recommended dose is 120 mg of orlistat orally 3 times daily, taken with a meal containing fat or within 1 hour after a meal. Patients should continue to follow a nutritionally balanced, mildly hypocaloric diet in which approximately 30 % of calories are derived from fat. Daily intake of fat, carbohydrates, and protein should be distributed evenly among the three meals. This medicine may be omitted if a meal is skipped or if the meal contains no fat. Because this medicine may reduce the absorption of some fat-soluble vitamins and beta-carotene, patients are advised to take a multivitamin containing fat-soluble vitamins to ensure adequate nutrition. The vitamin supplement should be taken at least 2 hours before this medicine or at least 2 hours after it, such as at bedtime. Taking more than 120 mg of this medicine per dose, 3 times daily, does not increase its efficacy. Based on measurements of fecal fat, the effect of this medicine appears approximately 24 ∼ 48 hours after administration. After treatment is discontinued, fecal fat content generally returns to pretreatment levels within 48 ∼ 72 hours. The efficacy and safety of this medicine for periods exceeding 4 years have not been evaluated. No studies have been conducted in patients with hepatic and/or renal impairment or in elderly patients.
Children under 12 years of age: No studies have been conducted.
This medication should not be used in patients with chronic malabsorption syndrome or biliary obstruction. It should also not be taken by individuals with allergies to the drug or any of its ingredients, pregnant women, women who may become pregnant, or breastfeeding mothers. Patients with liver function problems should use this medication with caution. If symptoms of liver dysfunction occur during treatment, a doctor should be notified immediately, and liver function tests should be performed. Patients with hyperoxaluria or calcium oxalate kidney stones should also use caution. Adverse reactions mainly appear in the gastrointestinal system and can include abdominal distension, flatulence, constipation, and oily stools. These symptoms are generally mild and temporary, usually occurring within three months after beginning treatment and diminishing over time. However, in some patients, gastrointestinal adverse effects may persist for more than six months. Rare side effects such as liver damage, hypersensitivity reactions, pancreatitis, hypoglycemia, and seizures have also been reported during treatment. If allergy symptoms such as skin rash, itching, or difficulty breathing occur, medical assistance should be sought immediately. This medication can reduce the absorption of fat-soluble vitamins and beta-carotene, so it is advisable to take vitamin supplements, which should be taken at least 2 hours before or after taking this medication. Taking this medication with a high-fat meal can increase gastrointestinal adverse reactions, so it is important to distribute total fat intake evenly across three meals. Extreme weight loss can also increase the risk of gallstones, so caution is advised. This medication may interact with other medications, especially cyclosporine, anticoagulants, antiepileptics, and antiretrovirals, so it should be taken under the supervision of a doctor, along with close monitoring through blood tests. Pregnant and breastfeeding women should not take this medication, and it has not been confirmed safe for children under 12 years. In the case of overdose, no specific serious adverse reactions have been reported, but observation by medical personnel is necessary. Finally, this medication should be stored in a place out of reach of children, and kept away from light and moisture.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent moisture, and kept in a cool place below 25 degrees Celsius. Proper storage will help maintain the effectiveness of the medication and prevent degradation.
A green hard capsule containing white to pale yellow pellets.
90 capsules/box [10 capsules/PTP x 9], 300 capsules/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOrlistat 60mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Orlistat 120mg
Hard capsule · Prescription medication
Jongkun Dang Co., Ltd.

Orlistat 120mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Orlistat 120mg
Hard capsule · Prescription medication
Genupharm Co., Ltd.

Orlistat 120mg
Hard capsule · Prescription medication
Mothers Pharmaceutical Co., Ltd.

Orlistat 60mg
Hard capsule · Prescription medication
Genupharm Co., Ltd.

Orlistat 120mg
Hard capsule · Prescription medication
Alvozen Korea Co., Ltd.

Orlistat 60mg
Hard capsule · Prescription medication
Albozen Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.